COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation

Introduction The clinical manifestations of COVID-19 infection in recipients of allogeneic hematopoietic stem cell transplantation (HSCT) have been reported in multiple retrospective cohorts of patients, but there have been no prospective studies to date. Previous studies report that HSCT recipients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucchini, Giovanna, Cozma, Elena, Jackson, Aimee, Gilmour, Kimberly, Protheroe, Rachel Elizabeth, Tholouli, Eleni, Wynn, Robert F, Wilson, Keith, Peggs, Karl S, Potter, Victoria, Parker, Anne, Craddock, Charles, Paneesha, Shankara, Nicholson, Emma, Marks, David I., Mirci-Danicar, Oana, Parrish, Christopher, Martin, Alexander M, McIlroy, Graham, Bishop, Rebecca, Collings, Rebecca, Williams, Ellie, Amrolia, Persis J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
721.Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701672/
http://dx.doi.org/10.1182/blood-2021-146515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701672/
http://dx.doi.org/10.1182/blood-2021-146515

Ejemplares similares